Cadila Pharmaceuticals Limited, mirtazapine 30mg tablets defect
The MHRA has published a class 4 medicines defect notification for mirtazapine 30mg tablets.
Published: 8 June 2026
Cadila Pharmaceuticals Limited reported an error with the European Article Number (EAN) barcode on the cartons of a batch of mirtazapine 30mg film-coated tablets distributed in Crescent Pharma Limited livery.
Further information, advice and details of the affected batch can be found on the MHRA website.